Estimations des analystes de Wall Street pour Predictive Oncology Inc. (POAI): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 0 |
| Conserver | 1 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 1 |
| Note moyenne (1-5) | 0.00 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-04-08 | $0.90 | ||
| 2025-11-14 | $-4.52 | $-1.35 | -234.8% |
| 2025-08-14 | $-3.30 | $-1.35 | -144.4% |
| 2025-05-15 | $-4.80 | $-1.35 | -255.6% |
| 2025-04-01 | $-0.25 | $-0.25 | +0.0% |
| 2024-11-13 | $-5.40 | $-4.80 | -12.5% |
| 2024-08-14 | $-10.19 | ||
| 2024-05-15 | $-15.59 |
Ratios de valorisation
| Prix / Valeur comptable | 2.84 |
| EV / EBITDA | -0.50 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $456495 | $654836 | $1.4M | $1.4M | $1.3M | $1.4M | $1.5M | $1.6M | $1.6M | $125284 |
| Coût des Ventes | $181620 | $148045 | $415764 | $531810 | $447192 | $487024 | $505107 | $609212 | $826137 | $72622 |
| Marge Brute | $274875 | $506791 | $995891 | $879755 | $805080 | $933656 | $1.0M | $1.0M | $797680 | $52662 |
| R&D | $406000 | $289000 | $1.9M | $3.0M | $372710 | $315850 | $320320 | $122307 | $25987 | $2.1M |
| Frais Généraux | $5.6M | $8.3M | $7.0M | $11.7M | $10.9M | $11.7M | $12.5M | $9.1M | $8.9M | $26.3M |
| Charges Opérationnelles | $6.8M | $8.3M | $8.9M | $23.5M | $26.2M | $21.4M | $27.0M | $13.1M | $11.7M | $28.5M |
| Résultat Opérationnel | -$6.5M | -$7.7M | -$7.9M | -$22.6M | -$25.4M | -$20.4M | -$26.0M | -$12.1M | -$10.9M | -$28.4M |
| EBITDA | -$6.4M | -$6.0M | -$7.7M | -$13.1M | -$11.5M | -$12.1M | -$14.0M | -$11.8M | -$10.2M | -$232.2M |
| Charges d'Intérêt | $3 | 0 | 0 | 0 | 0 | 0 | $10.7M | 0 | 0 | 0 |
| Résultat Avant Impôts | -$6.5M | -$7.7M | -$10.1M | -$19.4M | -$25.9M | -$20.3M | -$25.7M | -$12.0M | -$10.9M | -$232.9M |
| Impôts | 0 | $50503 | 0 | 0 | 0 | -$661658 | 0 | 0 | 0 | 0 |
| Résultat Net | -$6.5M | -$7.7M | -$10.1M | -$19.4M | -$25.9M | -$19.7M | -$25.7M | -$14.0M | -$12.2M | -$233.1M |
| BPA | $-462.28 | $-188.69 | $-157.40 | $-137.14 | $-44.25 | $-7.16 | $-6.98 | $-3.48 | $-2.24 | $-13.37 |
| BPA Dilué | $-462.28 | $-188.69 | $-157.40 | $-137.20 | $-44.25 | $-7.20 | $-6.98 | $-3.48 | $-2.24 | $-13.37 |
| Actions en Circulation (Diluées) | $14115 | $31815 | $64080 | $143505 | $597510 | $2.7M | $3.7M | $4.0M | $5.5M | $17.4M |
Prix
| Prix | $4.91 |
| Capitalisation | $4M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: AIM · AMIX · BNGO · CYCN · GBS · HSCS · KTTA
Explorer le secteur: Healthcare · Medical - Instruments & Supplies
Plus de sections de POAI: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions